Paula Littlejohn

Paula Littlejohn

Auto-generated profile, based on publicly available information

Paula Littlejohn

Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, University of British Columbia (UBC), Vancouver, Canada

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2022 in Gastroenterology
Verified
Journal Article
Open access
KBKylynda C. Bauer
Kylynda C. Bauer
PLPaula T. Littlejohn
Paula T. Littlejohn
VAVictoria Ayala
Victoria Ayala
ACAnna Creus-Cuadros
Anna Creus-Cuadros
BFB. Brett Finlay
B. Brett Finlay
Nonalcoholic fatty liver disease (NAFLD) is a chronic condition affecting one quarter of the global population. Although primarily linked to obesity and metabolic syndrome, undernutrition and the altered (dysbiotic) gut microbiome influence NAFLD progression. Both undernutrition and NAFLD prevalence are predicted to considerably increase, but how the undernourished gut microbiome contributes to hepatic pathophysiology remains far less studied. Here, we present undernutrition conditions with fatty liver features, including kwashiorkor and micronutrient deficiency. We then review the gut microbiota-liver axis, highlighting key pathways linked to NAFLD progression within both overnutrition and undernutrition. To conclude, we identify challenges and collaborative possibilities of emerging multiomic research addressing the pathology and treatment of undernourished NAFLD.

28 January 2021 in BMC Medicine
Verified
Journal Article
Open access
PDF file
PLPaula Littlejohn
Paula Littlejohn
BFB. Brett Finlay
B. Brett Finlay
Background: It is estimated that the COVID-19 pandemic will drastically increase all forms of malnutrition. Of particular concern, yet understated, is the potential to increase the double burden of malnutrition (DBM) epidemic. This coexistence of undernutrition together with overweight and obesity, or diet-related non-communicable disease (NCD), within low- to middle-income countries (LMICs) is increasing rapidly. Although multiple factors contribute to the DBM, food insecurity (FI) and gut microbiota dysbiosis play a crucial role. Both under- and overnutrition have been shown to be a consequence of food insecurity. The gut microbiota has also been recently implicated in playing a role in under- and overnutrition, with altered community structure and function common to both. The pandemic has already caused significant shifts in food availability which has immediate effects on the gut microbiome. In this opinion paper, we discuss how COVID-19 may indirectly exacerbate the DBM through food insecurity and the gut microbiome. Main text: The World Food Programme (WFP) estimates that 265 million people in LMICs will experience acute hunger in 2020 due to the pandemic, nearly doubling the original projection of 135 million. Global border closures to food trade, loss of food production, and stark decline in household income will exacerbate starvation while simultaneously necessitating that families resort to calorie-dense, nutrient-poor foods, thereby increasing obesity. While food insecurity, which is the persistent lack of consistent access to adequate and nutrient-rich foods, will primarily drive nutrition behavior, the gut microbiome is perhaps a key biological mechanism. Numerous human and animal studies describe low diversity and an increase in inflammatory species as characteristic features of the undernourished and overnourished gut microbiota. Indeed, fecal transplant studies show that microbiota transfer from undernourished and overnourished humans to germ-free mice lacking a microbiome transfers the physical and metabolic phenotype, suggesting a causal role for the microbiota in under- and overnutrition. The observed microbiome dysbiosis within severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) coupled with the DBM presents a viscous cycle. Conclusion: Low- to mid-income countries will likely see an increase in the DBM epidemic. Providing access to nutritious foods and protecting individuals’ gut microbiome to “flatten the curve” of the DBM trajectory should be prioritized.

16 November 2023 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
PLPaula T. Littlejohn
Paula T. Littlejohn
AMAvril Metcalfe-Roach
Avril Metcalfe-Roach
EPErick Cardenas Poire
Erick Cardenas Poire
RHRavi Holani
Ravi Holani
Haggai Bar-YosephHaggai Bar-Yoseph
Haggai Bar-Yoseph
BFB. Brett Finlay
B. Brett Finlay

28 June 2019 in Journal of Medical Internet Research
Verified
Journal Article
Open access
VAVanessa Araujo Almeida
Vanessa Araujo Almeida
PLPaula Littlejohn
Paula Littlejohn
ICIrene Cop
Irene Cop
EBErin Brown
Erin Brown
RARimi Afroze
Rimi Afroze
Karen DavisonKaren Davison
Karen Davison
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

14 November 2024 in BMJ Nutrition, Prevention & Health
Verified
Journal Article
Open access
PDF file
PLPaula T Littlejohn
Paula T Littlejohn
TATaiba Jibril Afaa
Taiba Jibril Afaa
Inflammatory bowel disease (IBD) represents two idiopathic conditions (Crohn’s and ulcerative colitis (UC)) of chronic inflammation of the gastrointestinal tract affecting all ages with no known cure. Approximately 4.9 million cases of IBD were reported in 2019, and this number is projected to increase. 1 IBD is driven by intestinal epithelial damage and dysfunction, dysbiotic gut microbiome and inappropriate immune response in genetically susceptible individuals. Clinical presentations are abdominal pain, diarrhoea, rectal bleeding, malnutrition and poor growth in children and adolescents.2 Diagnosis involves taking a comprehensive history, conducting relevant investigations, performing endoscopy and biopsy on patients with relevant clinical features by a well-trained clinician. Specific tissue histological findings such as neutrophilic inflammation, cryptitis and crypt abscess for UC and non-caseating granuloma in Crohn’s disease (CD) and radiological imaging are used to confirm the diagnosis.3 A delay in diagnosis or misdiagnosis resulting in untreated IBD can lead to worsened clinical outcomes. This includes persistent inflammation, development of systemic symptoms, potential complications like stenosis and fistulas with increased risk of bowel surgery.4 5 Compounding this problem are nutritional deficiencies, a frequent complication and comorbidity of IBD. Overt malnutrition (ie, undernutrition and overnutrition) like IBD is characterised by chronic inflammation, mucosal damage, intestinal barrier dysfunction, gut microbiome dysbiosis, altered immune response and malabsorption.6 In countries where childhood undernutrition is endemic, this presents an additional challenge in distinguishing malnutrition secondary to IBD. Additionally, nutritional deficiencies can worsen IBD pathophysiology and impede therapeutic response complicating disease management.6 This may lead to further misdiagnosis and underreporting of IBD’s prevalence in sub-Saharan Africa. Therefore, there is a crucial need to understand these challenges and underlying malnutrition in these settings. Moreover, reconciling malnutrition-driven pathologies may reveal unique subtypes of IBD, requiring a different approach to diagnosis and management.

11 June 2018 in JMIR Research Protocols
Verified
Journal Article
Open access
PLPaula Littlejohn
Paula Littlejohn
ICIrene Cop
Irene Cop
EBErin Brown
Erin Brown
RARimi Afroze
Rimi Afroze
Karen DavisonKaren Davison
Karen Davison
Background: Although nutrition interventions are a widely accepted resource for the prevention of long-term health conditions, current approaches have not adequately reduced chronic disease morbidity. Nutrigenomics has great potential; however, it is complicated to implement. There is a need for products based on nutrition-related gene test results that are easily understood, accessible, and used. Objective: The primary objective of this study was to compare a nonpractitioner-assisted direct-to-consumer self-driven approach to nutrigenomics versus an integrated and personalized practitioner-led method. Methods: This 4-month study used a mixed-methods design that included (1) a phase 1 randomized controlled trial that examined the effectiveness of a multifaceted, nutrition-based gene test (components assessed included major nutrients, food tolerances, food taste and preferences, and micronutrients) in changing health behaviors, followed by (2) a qualitative investigation that explored participants' experiences. The study recruited 55 healthy males and females (aged 35-55 years) randomized as a 2: 1 ratio where 36 received the intervention (gene test results plus integrated and personalized nutrition report) and 19 were assigned to the control group (gene test results report emailed). The primary outcomes of interest measures included changes in diet (nutrients, healthy eating index), changes in measures on General Self-efficacy and Health-Related Quality of Life scales, and anthropometrics (body mass index, waist-to-hip ratio) measured at baseline, post intervention (3 and 6 weeks), and the final visit (week 9 post intervention). Results: Of the 478 individuals who expressed interest, 180 were invited (37.7%, 180/478) and completed the eligibility screening questionnaire; 73 of the 180 invited individuals (40.5%) were deemed eligible. Of the 73 individuals who were deemed to be eligible, 58 completed the baseline health questionnaire and food records (79%). Of these 58 individuals, 3 were excluded either because they did not complete all required data collection forms or were later found to be ineligible. The final sample (n=55) was mostly female (75%), married (85%), and those who had completed postsecondary education (62%). Conclusions: This study will leverage quantitative and qualitative findings, which will guide the development of nutrigenomics-based products in electronic formats that are user-friendly for consumers and health professionals. Although the quantitative data have not been analyzed yet, the overwhelming interest in the study and the extremely high retention rate show that there is a great degree of interest in this field. Given this interest and the fact that nutrigenomics is an evolving science, a need for continued research exists to further the understanding of the role of genetic variation and its role and applications in nutrition practice.